Sort
50,496 grants matching “lung cancer”
Extracellular Sulfatases As Novel Biomarkers For Early Detection of Cancer
$428,830Hassan Lemjabbar-Alaoui · University Of California, San Francisco · U01 · FY2015 · CA
Screening and Risk Biomarkers for Ovarian Cancer in EPIC Specimens
$428,829Daniel William Cramer · Brigham And Women'S Hospital · R01 · FY2015 · CA
Contemporary Venous Thromboembolism Treatment
$428,815Pamela L. Lutsey · University Of Minnesota · R01 · FY2020 · HL
Project 3: MITF in Drug Resistance and Metabolism in Melanoma
$428,781Jeffrey W Smith · Sanford Burnham Prebys Medical Discovery Institute · P01 · FY2016 · CA
Studies of Non-Ionizing Radiation-Related Cancer
$428,758Elizabeth Cahoon · Division Of Cancer Epidemiology And Genetics · ZIA · FY2023 · CA
Functional Determinants of Metastatic Dormancy
$428,739Julio A Aguirre-Ghiso · Icahn School Of Medicine At Mount Sinai · R01 · FY2017 · CA
Development of TIMP-2 derivatives or strategies as biologic therapies for cancer
$428,728William Stetler-Stevenson · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
The role of TIM-3 in regulating T cell function during tuberculosis
$428,728Samuel M Behar · Brigham And Women'S Hospital · P01 · FY2016 · AI
Chemokine regulation of immune cell recruitment
$428,712Terry W Wright · University Of Rochester · R01 · FY2010 · HL
Investigating CREBBP as a tumor suppressor in small cell lung cancer
$428,702David Macpherson · Fred Hutchinson Cancer Research Center · R01 · FY2019 · CA
CARM1-mediated regulation of YAP1 as a therapeutic target in lung cancer
$428,694Joseph Kissil · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2023 · CA
CARM1-mediated regulation of YAP1 as a therapeutic target in lung cancer
$428,692Joseph Kissil · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2022 · CA
Spatial and temporal tumor-immune co-evolution and interactions that model lung adenocarcinoma development
$428,656Humam Kadara · University Of Tx Md Anderson Can Ctr · U01 · FY2023 · CA
"Neutrophil Elastase Links Idiopathic Pulmonary Fibrosis and Lung Cancer"
$428,600A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2012 · HL
"Neutrophil Elastase Links Idiopathic Pulmonary Fibrosis and Lung Cancer"
$428,600A. McGarry Houghton · Fred Hutchinson Cancer Research Center · R01 · FY2016 · HL
Molecular dissection of Lkb1-mediated tumor suppression
$428,592Monte Meier Winslow · Stanford University · R01 · FY2018 · CA
A Randomized Controlled Trial of Dexamethasone for Dyspnea in Cancer Patients
$428,588David Hui · University Of Tx Md Anderson Can Ctr · R01 · FY2017 · CA
The role of EGFR as a mechanism of therapeutic resistance in gene fusion positive lung cancer.
$428,571Robert C Doebele · University Of Colorado Denver · R01 · FY2017 · CA
Epidemiologic and Basic Science in Cancer Prevention
$428,558James Marshall · Roswell Park Cancer Institute Corp · R25 · FY2007 · CA
NG2-PG in tumor vascularization and progression
$428,536William B Stallcup · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2013 · CA
Characterizing and predicting comorbidity cascade among men and women with and without HIV by harnessing data from MWCCS and electronic medical records
$428,493Jing Sun · Johns Hopkins University · R21 · FY2025 · AG
Genetic dissection of oncogenic Kras signaling
$428,454Monte Meier Winslow · Stanford University · R01 · FY2025 · CA
Personalization and Failure Testing of Dual Switch Gene Drives in Lung Cancer
$428,442Justin Pritchard · Pennsylvania State University, The · U01 · FY2022 · CA
THE BIOMARKER DEVELOPMENT LABORATORY AT MOFFITT (BEDLAM)
$428,425University Of South Florida · U01 · FY2000 · CA
Investigation of CXCR7 signaling in EGFR TKI resistant NSCLC
$428,376Takeshi Shimamura · University Of Illinois At Chicago · R01 · FY2019 · CA